[go: up one dir, main page]

EP3367818A1 - Aliment (iii) - Google Patents

Aliment (iii)

Info

Publication number
EP3367818A1
EP3367818A1 EP15822917.9A EP15822917A EP3367818A1 EP 3367818 A1 EP3367818 A1 EP 3367818A1 EP 15822917 A EP15822917 A EP 15822917A EP 3367818 A1 EP3367818 A1 EP 3367818A1
Authority
EP
European Patent Office
Prior art keywords
chroman
formula
juice
hydroxy
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP15822917.9A
Other languages
German (de)
English (en)
Inventor
Johannes KIEFL
Susanne Paetz
Jakob Ley
Michael Backes
Joachim Hans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Symrise AG
Original Assignee
Symrise AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symrise AG filed Critical Symrise AG
Publication of EP3367818A1 publication Critical patent/EP3367818A1/fr
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20Synthetic spices, flavouring agents or condiments
    • A23L27/205Heterocyclic compounds
    • A23L27/2052Heterocyclic compounds having oxygen or sulfur as the only hetero atoms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20Synthetic spices, flavouring agents or condiments
    • A23L27/204Aromatic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/84Flavour masking or reducing agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/86Addition of bitterness inhibitors
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/16Taste affecting agent
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/21Plant extracts
    • A23V2250/2116Flavonoids, isoflavones
    • A23V2250/21162Citrus flavonoids

Definitions

  • the invention is in the field of food and citrus and especially orange products containing foods with added neoflavonoids with the aim of reducing the unpleasant, especially the sour and bitter taste of these foods.
  • Foodstuffs in particular beverages, which are mainly produced from fruits of various citric species, play a very prominent role in the international food market.
  • orange juice (Citrus x sinensis L. or Citrus x aurantium) in the form of juice or reconstituted juice from concentrate and foods based on orange juice such as nectars or fruit juice drinks should be mentioned.
  • a balanced sweetness in combination with an acidic taste impression and also a certain bitterness are decisive for the sensory quality of these drinks.
  • EP 2570035 Bl SYM RISE
  • certain neoflavonoids are generally suitable to reduce the bitter taste of certain bitter flavors.
  • the enhancement of sweet taste by certain neoflavonoids has been described in EP 2570036 Bl (SYM RISE).
  • these substances might also be suitable for reducing the acidic taste, especially in sour and bitter, orally consumable citrus products.
  • flavourings should be naturally occurring and preferably obtained from ingredients of the genus Citrus.
  • a first subject of the invention relates to foods containing
  • E is either OH or both E together represent an O
  • R 1 is independently of the other radical R 1, hydrogen or OR a , where R a is hydrogen, C 1 -C 5 -alkyl or C 2 -C 5 -alkenyl,
  • R 2 is independently of the other radicals R 2, hydrogen or OR b , where R b is hydrogen, C 1 -C 5 -alkyl or C 2 -C 5 -alkenyl,
  • component (b) is present in an amount sufficient to improve the acidic and / or bitter taste of component (a).
  • the foods of the present invention are preferably beverages or desserts.
  • citrus-containing beverages include the group formed by freshly squeezed, direct juices, reconstituted juices from juice concentrate, nectars, juice spritzers, juice-containing soft drinks, juice-containing dairy products, juice-containing carbonated beverages and juice-containing ice tea.
  • citrus-containing desserts are in the group formed by yogurts, frozen ice-creams, sorbets, ice cream, creams, puddings, fillings for chocolates or biscuit products, jams and dried juice or fruit preparations.
  • citrus products for the purposes of the present invention, the juice, the marrow, the meat, the shells and all other ingredients of citrus fruits to understand; it is subsequently used as a synonym for group (a).
  • Citrus fruits whose bitter and / or sour taste is to be improved include oranges, grapefruit, lemons, limes, mandarins and their mixtures.
  • group (a) comprises acidic and bitter orange products: orange varieties derived from fruits of the genus Citrus (Citrus x sinensis L. or Citrus x aurantium, Var. Hamlin, Valencia), in particular products derived from HLB-infected trees, such as juices, juice concentrates, juice fractions with or without albedo, with or without pulp, due to a proportion of oranges ripe for oranges.
  • Citrus x sinensis L. or Citrus x aurantium, Var. Hamlin, Valencia products derived from HLB-infected trees, such as juices, juice concentrates, juice fractions with or without albedo, with or without pulp, due to a proportion of oranges ripe for oranges.
  • the citrus products that form group (a) should have a pH in the range of 3 to 6.
  • E is either OH or both E together represent an O
  • R 1 is independently of the other radical R 1, hydrogen or OR a , where R a is hydrogen, C 1 -C 5 -alkyl or C 2 -C 5 -alkenyl,
  • R 2 is independently of the other radicals R 2, hydrogen or OR b , where R b is hydrogen, C 1 -C 5 -alkyl or C 2 -C 5 -alkenyl,
  • the compounds of formula (I) can be combined in preferred embodiments as pure enantiomers or as mixtures of enantiomers in any ratio with each other.
  • the compounds of formula (I) are in the form of racemic mixtures, i. used as racemates.
  • R 1 and R 2 independently of the other radical R 1 and R 2, are each hydrogen, hydroxy or a radical selected from the group consisting of
  • R 1 is H or OH, and / or one or more of the radicals R 1 or R 2 in the formula (I) is a hydroxy group.
  • Preferred according to the invention is the above-mentioned use, wherein one, two, more or all of the compounds used are each selected from the group consisting of the compounds of formula (I) and their physiologically acceptable salts, wherein
  • R 1 is independently of the other radical R 1, hydrogen or hydroxy
  • R 2 is independently of the other radicals R 2, hydrogen, hydroxyl, methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, tert-butoxy or OR b means
  • R b is C 5 -alkenyl, again preferably R b is prenyl, where appropriate two directly adjacent radicals R 2 together represent a group OCH 2 0, wherein preferably one or more of the radicals R 1 or R 2 denotes a hydroxy group.
  • a compound of formula (I) has a total of one, two, three, four or five hydroxy groups.
  • the compounds of the formula (I) to be used according to the invention may correspond to structural formulas (IA) or (IB) in which R 1 and R 2 in each case have the abovementioned meaning:
  • the lactone ring of the compound of formula (IA) can be opened and the compound of formula (IA) in equilibrium with the corresponding "open-chain" compound of formula (IB), as shown schematically below where M + represents a (preferably physiologically acceptable) counter cation (and wherein the counter cation preferably has the meaning given below):
  • Another aspect of the present invention relates to the use of a substance mixture comprising one or more compounds of the formula (I-Al) and one or more compounds of the formula (I-A2), and / or their physiologically acceptable salts.
  • R 2 is independently of the other radicals R 2, hydrogen, hydroxyl, methoxy, ethoxy, n-propoxy or iso-propoxy, preferably H, OH, OCH 3 or OCH 2 CH 3 , where appropriate two immediately adjacent radicals R 2 together form a group OCH 2 Represent 0,
  • radicals R 2 signify a hydroxy group, and their physiologically acceptable salts.
  • R 2 independently of the other radicals R 2, is hydrogen, hydroxyl, methoxy, ethoxy, n-propoxy or iso Propoxy means, preferably H, OH, OCH 3 or OCH 2 CH 3 , wherein optionally two immediately adjacent radicals R 2 together represent a group OCH 2 0, and wherein preferably at least one of the radicals R 2 represents a hydroxy group.
  • the configuration on the chiral carbon atom ie, at the "*" marked position in the above formula (II) and (II-A)) may be (R) or (S), respectively.
  • a compound of the formula (II) or a compound of the formula (II-A) preferably has one, two, three, four or five hydroxyl groups, more preferably in each case together with one, two, three or four hydroxyl groups, particularly preferably a total of two, three or four hydroxy groups.
  • Particularly preferred according to the invention is the use of one or more compounds of the formulas (5) - (66) and / or their physiologically acceptable salts (5) (4S) -5,7-dihydroxy-4- (3-hydroxy-) 4-methoxy-phenyl) -chroman-2-one
  • neoflavonoids of the formula (I) may also be present in certain plants or parts of plants.
  • neoflavonoid compounds (9), (10), (11), (12), (13), (14), (21), (22), (29), (30) , (41) and (42) as well as the neoflavonoids (63), (64), (65) and (66) which are also included in the general formula (I) which have been found in Polygonum perfoliatum (see Planta Medica 1999, 65, 671 Chin, J. Appl. Environ., Biol., 2009, 15, 615-620) and their physiologically acceptable salts.
  • Also included in the preferred embodiment is a salt of one of these compounds, a mixture of the compounds, two different salts of these compounds of the formulas and one of these compounds and a salt of these compounds.
  • one or more of the neoflavonoids of the formula (I) to be used according to the invention can also be used according to the invention in the form of vegetable extracts, in particular in the form of plant extracts of Polygonum perfoliatum.
  • neoflavonoids of the formula (I) and / or (II) can be present in particular in the form of their cationic salts, for example as sodium salts, potassium salts or ammonium salts.
  • neoflavonoids of the formula (Ia) and / or (Ib) relative to the component (a) in amounts of about 5 to about 1000 ppm and in particular about 30 to about 250 ppm and more preferably about 50 to about 100 ppm are present, added or selectively produced.
  • the foodstuffs may contain as component (c) further flavoring or flavoring preparations.
  • these may be selected from substances for altering or masking an unpleasant taste impression and / or for enhancing a pleasant taste impression or flavoring agents are preferably selected from the following group: hesperetin as described in EP 2,368,442-Bl or EP 1,909,599-B1, hydroxybenzoic acid amides, such as for example 2,4-dihydroxybenzoic acid vanillylamide (in particular those as described in WO 2006/024587), 4-hydroxydihydrochalcones (preferably as described in US 2008/0227867 Al and WO 2007/107596), in particular phloretin and davidigenin, hesperetin as in WO 2007/014879, or extracts of Rubus suavissimus as described in US Provisional Application 61 / 333,435 (Symrise) and the patent applications based thereon, 3,7'-dihydroxy-4'-methoxy
  • flavorings or flavorings may be selected from the list of volatile flavoring agents, eg, acetaldehyde, acetophenone, alpha-cadinol, alpha copaen, alpha-cubebene, alpha-humulene, alpha-pinene, alpha-terpinene, alpha-terpineol, anisaldehyde, benzaldehyde , Benzophenone, beta-copaen, beta-cubeben, beta-cyclocitral, beta-elemen, beta-lonone, beta-myrcene, beta-ocimene, beta-pinene, butanol, butylacetate, camphene, caryophyllene, cis-4-decenal , cis-4-heptenal, cis-3-hexenal, cis-3-hexenol, cis-8-tetradecenal, citric, citronellol, citronella
  • the proportion of neoflavonoids in these preparations may be from 0.1 to 99.9% by weight, preferably from about 0.5 to about 25% by weight and in particular from about 1 to about 10% by weight.
  • Further flavoring substances are the abovementioned substances.
  • the flavorings may be encapsulated and / or adsorbed and / or emulsified, or incorporated into the formulation.
  • Both the neoflavonoids which form group (b) and aroma preparations containing these substances can be encapsulated and then also added as capsules to the food.
  • Capsules are spherical aggregates containing at least one solid or liquid core, which is enclosed by at least one continuous shell.
  • the fragrances can be encapsulated by coating materials and present as macrocapsules with diameters of about 0.1 to about 5 mm or microcapsules with diameters of about 0.0001 to about 0.1 mm.
  • Suitable coating materials are, for example, starches, including their degradation products and chemically or physically generated derivatives (especially dextrins and maltodextrins), gelatin, gum arabic, agar-agar, ghatti gum, gellan gum, modified and unmodified celluloses, pullulan, Curdlan, carrageenans, alginic acid, alginates, pectin, inulin, xanthan gum and mixtures of two or more of these substances.
  • the solid encapsulating material is preferably a gelatin (especially pork, beef, poultry and / or fish gelatin), which preferably has a threshold factor of greater than or equal to 20, preferably greater than or equal to 24.
  • gelatin especially pork, beef, poultry and / or fish gelatin
  • gelatin is particularly preferred because it is well available and can be obtained with different threshold factors.
  • maltodextrins especially based on cereals, especially corn, wheat, tapioca or potatoes
  • DE values in the range of 10 to 20.
  • celluloses eg cellulose ethers
  • alginates eg Sodium alginate
  • carrageenan eg, beta, jota, lambda and / or kappa carrageenan
  • gum arabic curdlan and / or agar agar.
  • alginate capsules as described in detail in the following documents: EP 0389700 AI, US 4,251,195, US 6,214,376, WO 2003 055587 or WO 2004 050069 AI.
  • the shell of the capsules consists of melamine-formaldehyde resins or coacervation products of cationic monomers or biopolymers (such as chitosan) and anionic monomers such as (meth) acrylates or alginates.
  • the capsules are generally finely dispersed liquid or solid phases coated with film-forming polymers, during the production of which the polymers precipitate on the material to be enveloped after emulsification and coacervation or interfacial polymerization.
  • molten waxes are taken up in a matrix ("microsponge") which, as microparticles, can additionally be coated with film-forming polymers
  • microsponge a matrix
  • particles are coated alternately with polyelectrolytes of different charge (“layer-by-layer” process) ).
  • the microscopic capsules can be dried like powder.
  • multinuclear aggregates also called microspheres, are known which contain two or more cores distributed in the continuous shell material.
  • Mono- or polynuclear microcapsules can also be enclosed by an additional second, third, etc., sheath.
  • the shell may be made of natural, semi-synthetic or synthetic materials.
  • encapsulating materials are, for example, gum arabicum, agar agarose, agarose, maltodextrins, alginic acid or its salts, e.g. Sodium or calcium alginate, fats and fatty acids, cetyl alcohol, collagen, chitosan, lecithins, gelatin, albumin, shellac, polysaccharides such as starch or dextran, polypeptides, protein hydrolysates, sucrose and waxes.
  • Semisynthetic shell materials include chemically modified celluloses, especially cellulose esters and ethers, e.g. Cellulose acetate, ethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose and carboxymethylcellulose, and also starch derivatives, in particular starch ethers and esters.
  • Synthetic envelope materials are, for example, polymers such as polyacrylates, polyamides, polyvinyl alcohol or polyvinylpyrrolidone.
  • microcapsules of the prior art are the following commercial products (in parentheses is the shell material): Hallcrest Microcapsules (gelatin, gum arabic), Coletica Thalaspheres (marine collagen), Lipotec Millicapseln (alginic acid, agar-agar), Induchem Unispheres (lactose, microcrystalline cellulose, hydroxypropyl methylcellulose); Unicerin C30 (lactose, microcrystalline cellulose, hydroxypropylmethylcellulose), Kobo Glycospheres (modified starch, fatty acid esters, phospholipids), Softspheres (modified agar-agar) and Kuhs Probiol Nanospheres (phospholipids) as well as Primaspheres and Primasponges (chitosan, alginates) and Primasys (phospholipids) ,
  • Medium diameter microcapsules in the range of 0.0001 to 5, preferably 0.001 to 0.5 and in particular 0.005 to 0.1 mm, consisting of an enveloping membrane and a matrix containing the active ingredients can be obtained, for example, by
  • steps (a) and (c) are interchangeable insofar as anionic polymers are used instead of the cationic polymers in step (a) and vice versa.
  • Another object of the invention relates to a method for reducing the acidic and / or bitter taste of citrus fruit products, comprising the following steps:
  • neoflavonoids of the formula (I) and / or (II) or aromatic preparations containing them for improving the acidic and / or bitter taste of citrus fruit products wherein also here the amount added or the amount targeted again, preferably about 5 to about 1000 ppm, more preferably about 30 to about 250 ppm, based on the citrus component.
  • Pectin filling (quantities as wt .-%) The dry substances are dissolved in water and boiled together with the pectin and sodium citrate for about 3-5 minutes at 106 ° C to a Brix value of 77-78 °. Thereafter, the orange juice concentrate and the flavors are stirred. After gentle cooling, the mass is rapidly filled into molds and cooled.
  • the emulsifier and stabilizer is mixed with sugar and dissolved in water; Glucose syrup is added and dissolved. The mixture is then pasteurized and allowed to cool. Add the flavor ingredients and fruit juice concentrate to the mixture, adjust the pH of the 50% citric acid solution to 3.8-4.2, and freeze the preparation in an ice cream machine with 40-80% overrun.
  • Herbal liqueur (quantities as wt .-%)
  • Beer-mix drink with grapefruit (amounts in% by weight)

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne un aliment contenant (a) du jus, de la pulpe, de la chair, de l'écorce ou d'autres constituants d'au moins un agrume, (b), au moins un néoflavonoïde et éventuellement (c) d'autres agents ou préparations aromatisants, à la condition que le constituant (b) est présent dans une quantité suffisante pour réduire le goût acide et/ou amer du constituant (a).
EP15822917.9A 2015-10-29 2015-11-14 Aliment (iii) Pending EP3367818A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2015075187 2015-10-29
PCT/EP2015/076633 WO2017071784A1 (fr) 2015-10-29 2015-11-14 Aliment (iii)

Publications (1)

Publication Number Publication Date
EP3367818A1 true EP3367818A1 (fr) 2018-09-05

Family

ID=55080082

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15822917.9A Pending EP3367818A1 (fr) 2015-10-29 2015-11-14 Aliment (iii)

Country Status (3)

Country Link
US (1) US12262725B2 (fr)
EP (1) EP3367818A1 (fr)
WO (1) WO2017071784A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4262432A1 (fr) * 2020-12-21 2023-10-25 Symrise AG Utilisation de la naringénine pour améliorer la qualité gustative de la phlorétine
JP7511729B1 (ja) 2023-08-15 2024-07-05 サントリーホールディングス株式会社 容器詰め飲料の製造方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358960A (en) * 1918-03-30 1920-11-16 Kellogg Toasted Corn Flake Com Food product and method of preparing the same
US2791508A (en) * 1952-08-30 1957-05-07 Rivoche Eugene Joel Food products and method of making the same
NL180807C (nl) 1975-12-26 1987-05-04 Morishita Jintan Co Inrichting voor het vervaardigen van naadloze, met materiaal gevulde capsules.
JPH01193216A (ja) 1988-01-29 1989-08-03 Fuji Kapuseru Kk ソフトカプセル及び球状物
US6479146B1 (en) 1998-03-19 2002-11-12 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften, E.V. Fabrication of multilayer-coated particles and hollow shells via electrostatic self-assembly of nanocomposite multilayers on decomposable colloidal templates
US6214376B1 (en) 1998-08-25 2001-04-10 Banner Pharmacaps, Inc. Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture
US7485332B2 (en) * 1998-12-10 2009-02-03 Tropicana Products, Inc. Citrus peel juice
ATE304343T1 (de) 1999-07-02 2005-09-15 Cognis Ip Man Gmbh Mikrokapseln - iv
ES2213949T3 (es) 1999-07-02 2004-09-01 Cognis Iberia, S.L. Microcapsulas i.
ES2247749T3 (es) 1999-07-02 2006-03-01 Cognis Ip Management Gmbh Microcapsulas iii.
DE59908471D1 (de) 1999-07-02 2004-03-11 Cognis Iberia Sl Mikrokapseln - II
DE10122898A1 (de) * 2001-05-11 2002-11-14 Haarmann & Reimer Gmbh Verwendung von Hydroxyflavanonen zur Maskierung des bitteren Geschmacks
DE10164110A1 (de) 2001-12-24 2003-07-10 Dragoco Gerberding Co Ag Mononuklear gefüllte Mikrokapseln
ATE340566T1 (de) 2002-12-05 2006-10-15 Symrise Gmbh & Co Kg Nahtlose gefüllte kapseln
DE102004041496A1 (de) 2004-08-27 2006-03-02 Symrise Gmbh & Co. Kg Hydroxybenzoesäureamide und deren Verwendung zur Maskierung von bitterem Geschmack
CN101247734B (zh) 2005-07-27 2012-03-21 西姆莱斯有限责任两合公司 橙皮素用于增强甜味的用途
EP2368442B1 (fr) 2005-07-27 2014-12-17 Symrise AG Utilisation d'hespérétine pour améliorer le goût sucré
US8778987B2 (en) 2007-03-13 2014-07-15 Symrise Ag Use of 4-hydroxychalcone derivatives for masking an unpleasant taste
EP2008530B1 (fr) 2007-06-19 2011-01-19 Symrise AG Composition d'aromes destinée à réduire ou à supprimer une impression indésirable amère et astringente
EP2494874B1 (fr) 2007-10-09 2013-12-11 Tropicana Products, Inc. Maîtrise des caractéristiques d'un jus de fruit en matière de goût
EP2253226B1 (fr) 2009-05-15 2015-07-15 Leibniz-Institut für Pflanzenbiochemie (IPB) Utilisation de dérivés d'hydroxyflavane pour la modification du goût
ATE528997T1 (de) 2009-08-28 2011-11-15 Symrise Ag SÜßMITTELREDUZIERTE PRODUKTE, AROMAMISCHUNGEN DAFÜR SOWIE VERFAHREN ZUM HERSTELLEN SOLCHER PRODUKTE
PL2353403T3 (pl) 2010-02-01 2012-10-31 Symrise Ag Zastosowanie 1-(2,4-dihydroksy-fenylo)-3-(3-hydroksy-4-metoksy-fenylo)-propan-1-onu
EP2386211B1 (fr) 2010-05-11 2016-08-10 Symrise AG Utilisation de rubusoside pour la réduction ou la suppression d'impressions gustatives désagréables spécifiques
EP2517574B1 (fr) 2011-04-29 2015-11-11 Symrise AG Lignanes vanillyl spécifiques et leur utilisation comme améliorateurs de goût
EP2529633B1 (fr) 2011-06-01 2014-08-06 Symrise AG Préparations consommables oralement comprenant du triterpène et du triterpènglycoside au goût sucré
EP2570035B1 (fr) * 2011-09-15 2014-06-18 Symrise AG Utilisation de néoflavonoïdes pour la modification du goût
EP2570036B1 (fr) * 2011-09-15 2014-06-18 Symrise AG Utilisation de néoflavonoïdes précis pour le renforcement et/ou la production d'une impression sensorielle sucrée
EP2725026B1 (fr) 2012-10-29 2017-09-06 Symrise AG Néoflavonoïdes hétérocycliques comme masqueurs de goût
US20140348992A1 (en) * 2013-05-24 2014-11-27 Bucher-Alimentch Limited Juice processing
ES2738355T3 (es) 2013-10-31 2020-01-22 Symrise Ag Mezcla de sustancias

Also Published As

Publication number Publication date
WO2017071784A1 (fr) 2017-05-04
US20180360086A1 (en) 2018-12-20
US12262725B2 (en) 2025-04-01

Similar Documents

Publication Publication Date Title
EP2298084B1 (fr) Produits réduits en saccharine, mélanges d'arômes correspondant et procédé de fabrication de tels produits
EP2517574B1 (fr) Lignanes vanillyl spécifiques et leur utilisation comme améliorateurs de goût
EP2529633B1 (fr) Préparations consommables oralement comprenant du triterpène et du triterpènglycoside au goût sucré
EP3344068A1 (fr) Aliments contenant des produits d'agrumes et des 4-hydroxyflavanones ajoutées
EP2730178A1 (fr) Composition prise par voie orale
EP3383200B1 (fr) Compositions de matière
EP1977655A1 (fr) Compositions d'aromes d'alcamides comprenant de l'hespérétine et/ou des 4-hydroxydihydrochalcones et leurs sels destinées à renforcer les impressions sensorielles sucrées
EP2296496B1 (fr) Granulés pour la production de boissons instantanées à calories réduites
EP2725026B1 (fr) Néoflavonoïdes hétérocycliques comme masqueurs de goût
EP2865372B1 (fr) Capsules comprend actives
DE102012214560A1 (de) Bestimmte Lignane und deren Verwendung als Geschmacksverbesserer
EP2926673B1 (fr) Mélanges de composés
EP2883459B1 (fr) Compositions pour consommation orale
EP3367818A1 (fr) Aliment (iii)
EP3727010A1 (fr) Composition pour produit alimentaire
EP2659789B1 (fr) Compositions de matière
EP3641564B1 (fr) Agents aromatiques modulant la saveur

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180529

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20201130

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HANS, JOACHIM

Inventor name: BACKES, MICHAEL

Inventor name: LEY, JAKOB

Inventor name: PAETZ, SUSANNE

Inventor name: KIEFL, JOHANNES